PRKN and neurodegenerative disease: Next, we combined the 833 participants in a single population set and compared the burden of protein-altering variants between T1R-affected vs T1R-free participants for PRKN, LRRK2, and 22 additional PD-linked genes included in the neurodegenerative disease panel.